Search
for
Sort by
Research 331–360 of 353
- Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate
- Remodel the perifollicular microenvironment via Minoxidil-loaded microneedle patch and cold atmospheric plasma for treating androgenetic alopecia
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Retrospective Analysis of the Effect of Comorbid Atopic Dermatitis on the Treatment Response to Topical Immunotherapy in Pediatric Alopecia Areata Patients
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Comparison of Clinical Efficacy and Trichoscopic Changes in Alopecia Areata of the Scalp following Treatment with Intralesional Triamcinolone Acetonide and Autologous Platelet-Rich Plasma
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Nanotechnology-Based Strategies for Hair Follicle Regeneration in Androgenetic Alopecia
- New Treatment Options for Alopecia Areata
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Science and Technology of Hair Fibers
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- New Drugs for Alopecias
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- The efficacy and safety of diphenylcyclopropenone solutions in propylene glycol and isopropanol. A comparative study of two formulas used for the treatment of 100 patients with alopecia areata
- Efficacy and tolerance of 2,3-diphenylcyclopropenone in propylene glycol versus 2,3-diphenylcyclopropenone in isopropanol – a novel formula designed for the treatment of alopecia areata
- Patchy hair loss in an otherwise healthy man
- Oral Presentations
- The Effect of Drugs on Hair
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Alopecia Areata: An Updated Review for 2023
- Alopecia areata in children:, response to treatment with diphencyprone
- Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells
- Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Vitiligo as a Reaction to Topical Treatment with Diphencyprone
- Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis
- Retrospective review of diphencyprone in the treatment of alopecia areata